InsiderTrades

Form 4 for NHC NATIONAL HEALTHCARE CORP

Accepted 2025-06-30 00:00:00 ET · period of report 2025-06-26 · accession 0001437749-25-021575 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-30 2025-06-26 NHC Flatt Stephen Fowler CEO, Dir M - OptEx $63.96 +4,734 62.3K +8% +$302.8K
D 2025-06-30 2025-06-26 NHC Flatt Stephen Fowler CEO, Dir F - Tax $109.05 -3,557 58.8K -6% -$387.9K
D 2025-06-30 2025-06-26 NHC Flatt Stephen Fowler CEO, Dir M - OptEx $0.00 -4,734 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-26 M A 4,734 $63.96 62,313 D — — (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
2 Common Common Stock 2025-06-26 F D 3,557 $109.05 58,756 D — — (F2) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. (F3) Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form.
3 Derivative Option to Purchase Common Stock 2025-06-26 M D 4,734 $0.00 0 D $63.96 · 2023-02-18 to 2027-02-18 4,734 Common Stock (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).